{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:51:17Z","timestamp":1794379877888,"version":"4.9.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.pharmthera.2023.108578","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T21:04:14Z","timestamp":1702587854000},"page":"108578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases"],"prefix":"10.1016","volume":"253","author":[{"given":"Takuma","family":"Isshiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa","family":"Naiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Vierhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pareesa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parichehr","family":"Yazdanshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dvorkin-Gheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.J.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Ask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108578_bb0005","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/10520295.2020.1814966","article-title":"Role of bone marrow-derived mesenchymal stem cells in alleviating pulmonary epithelium damage and extracellular matrix remodeling in a rat model of lung fibrosis induced by amiodarone","volume":"96","author":"Abdel Halim","year":"2021","journal-title":"Biotechnic & Histochemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","article-title":"Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta","volume":"4","author":"Abreu","year":"2002","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0015","doi-asserted-by":"crossref","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1165\/ajrcmb.21.6.3719","article-title":"Enhanced Insulin-Like Growth Factor Binding Protein\u2013Related Protein 2 (Connective Tissue Growth Factor) Expression in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis","volume":"21","author":"Allen","year":"1999","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000168676","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis","volume":"77","author":"Aoki","year":"2009","journal-title":"Respiration; International Review of Thoracic Diseases"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20081991","article-title":"N-terminal domains of CCN family 2\/connective tissue growth factor bind to aggrecan","volume":"420","author":"Aoyama","year":"2009","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09059180.00003214","article-title":"Cellular interactions in the pathogenesis of interstitial lung diseases","volume":"24","author":"Bagnato","year":"2015","journal-title":"European Respiratory Review"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0040","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/rheumatology\/ket144","article-title":"Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis","volume":"52","author":"Bagnato","year":"2013","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1189\/jlb.0911449","article-title":"Thrombin-induced CCN2 expression in human lung fibroblasts requires the c-Src\/JAK2\/STAT3 pathway","volume":"93","author":"Bai","year":"2013","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphar.2018.00248","article-title":"An Adaptogen: Withaferin a ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, Matricelluar proteins, and cytokines","volume":"9","author":"Bale","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0055","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1172\/JCI68782","article-title":"Type 2 alveolar cells are stem cells in adult lung","volume":"123","author":"Barkauskas","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","article-title":"Epithelial\u2013mesenchymal transition in lung development and disease: Does it exist and is it important?","volume":"69","author":"Bartis","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0065","first-page":"109","article-title":"Effects of CTGF blockade on attenuation and reversal of radiation-induced pulmonary fibrosis","author":"Bickelhaupt","year":"2017","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0075","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1002\/art.24935","article-title":"Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts","volume":"60","author":"Bogatkevich","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0080","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1083\/jcb.114.6.1285","article-title":"Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10","volume":"114","author":"Bradham","year":"1991","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cytogfr.2012.07.001","article-title":"Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2)","volume":"24","author":"Charrier","year":"2013","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0095","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.bbrc.2017.12.112","article-title":"Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process","volume":"495","author":"Chen","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1523-1747.1999.00477.x","article-title":"Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: Involvement of Smad 3","volume":"112","author":"Chen","year":"1999","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0105","first-page":"8","article-title":"Connective tissue growth factor: From molecular understandings to drug discovery","author":"Chen","year":"2020","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0110","first-page":"7","article-title":"Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis","volume":"27","author":"Chilosi","year":"2010","journal-title":"Sarcoidosis, Vasculitis, and Diffuse Lung Diseases"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40618-018-0913-1","article-title":"Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model","volume":"42","author":"Comeglio","year":"2019","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","article-title":"Effect of pirfenidone on proliferation, TGF-\u03b2-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts","volume":"58","author":"Conte","year":"2014","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0125","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41385-020-00370-7","article-title":"Cellular and functional heterogeneity of the airway epithelium","volume":"14","author":"Davis","year":"2021","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0130","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic Sclerosis\u2013Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420923911","article-title":"Amelioration of paraquat-induced pulmonary fibrosis in mice by regulating miR-140-5p expression with the fibrogenic inhibitor Xuebijing","volume":"34","author":"Dong","year":"2020","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116064","article-title":"Connective tissue growth factor in idiopathic pulmonary fibrosis: Breaking the bridge","volume":"23","author":"Effendi","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0145","author":"FibroGen, Inc"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0150","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive Fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0155","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.apsb.2022.01.007","article-title":"Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases","volume":"12","author":"Fu","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0160","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jor.22142","article-title":"Mechanical stretch increases Smad3-dependent CCN2 expression in inner meniscus cells","volume":"30","author":"Furumatsu","year":"2012","journal-title":"Journal of Orthopaedic Surgery and Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2011.04.084","article-title":"Blockade of lysophosphatidic acid receptors LPAR1\/3 ameliorates lung fibrosis induced by irradiation","volume":"409","author":"Gan","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0170","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1074\/jbc.M313204200","article-title":"Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan","volume":"279","author":"Gao","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.598722","article-title":"A review of mesoporous silica nanoparticle delivery systems in chemo-based combination Cancer therapies","volume":"8","author":"Gao","year":"2020","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0180","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.yexcr.2012.06.015","article-title":"Angiotensin II increases CTGF expression via MAPKs\/TGF-\u03b21\/TRAF6 pathway in atrial fibroblasts","volume":"318","author":"Gu","year":"2012","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0185","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1007\/s00018-011-0782-7","article-title":"Roles for CCN2 in normal physiological processes","volume":"68","author":"Hall-Glenn","year":"2011","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0190","doi-asserted-by":"crossref","first-page":"36288","DOI":"10.1074\/jbc.M201674200","article-title":"Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165","volume":"277","author":"Hashimoto","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12931-018-0798-8","article-title":"Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Heukels","year":"2018","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12079-012-0177-z","article-title":"Promotion of Ccn2 expression and osteoblastic differentiation by actin polymerization, which is induced by laminar fluid flow stress","volume":"6","author":"Honjo","year":"2012","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2018.06.015","article-title":"Connective tissue growth factor stimulates osteosarcoma cell migration and induces osteosarcoma metastasis by upregulating VCAM-1 expression","volume":"155","author":"Hou","year":"2018","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bst0300211","article-title":"Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis","volume":"30","author":"Howell","year":"2002","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12929-021-00735-5","article-title":"Histone deacetylase 7 mediates endothelin-1-induced connective tissue growth factor expression in human lung fibroblasts through p300 and activator protein-1 activation","volume":"28","author":"Hua","year":"2021","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.toxlet.2020.06.009","article-title":"Roxadustat attenuates experimental pulmonary fibrosis in vitro and in vivo","volume":"331","author":"Huang","year":"2020","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0225","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.5213\/inj.2040152.076","article-title":"Combination therapy with polydeoxyribonucleotide and pirfenidone alleviates symptoms of acute respiratory distress syndrome in human lung epithelial A549 cells","volume":"24","author":"Hwang","year":"2020","journal-title":"International Neurourology Journal"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0230","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.3390\/ijms13078293","article-title":"Fasudil, a rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"13","author":"Jiang","year":"2012","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0235","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2016080826","article-title":"Connective tissue growth factor domain 4 amplifies fibrotic kidney disease through activation of LDL receptor-related protein 6","volume":"28","author":"Johnson","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0240","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/dvdy.24541","article-title":"Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease: Emt in lung development, homeostasis, and disease","volume":"247","author":"Jolly","year":"2018","journal-title":"Developmental Dynamics"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0245","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: Biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0250","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nrd3599","article-title":"Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets","volume":"10","author":"Jun","year":"2011","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0255","doi-asserted-by":"crossref","first-page":"17953","DOI":"10.1074\/jbc.RA118.004559","article-title":"Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation","volume":"293","author":"Kaasb\u00f8ll","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.omtn.2016.12.008","article-title":"Silencing of carbohydrate sulfotransferase 15 hinders murine pulmonary fibrosis development","volume":"6","author":"Kai","year":"2017","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0265","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1039\/C9NR10305H","article-title":"RNAi nanotherapy for fibrosis: Highly durable knockdown of CTGF\/CCN-2 using siRNA-DegradaBALL (LEM-S401) to treat skin fibrotic diseases","volume":"12","author":"Kang","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0270","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1172\/JCI139519","article-title":"Contributions of alveolar epithelial cell quality control to pulmonary fibrosis","volume":"130","author":"Katzen","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: Novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0280","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.neuron.2013.07.011","article-title":"Connective tissue growth factor regulates interneuron survival and information processing in the olfactory bulb","volume":"79","author":"Khodosevich","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0285","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1440-1681.2010.05431.x","article-title":"Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis","volume":"37","author":"Kim","year":"2010","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0290","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678457","article-title":"Roles of macrophage polarization and macrophage-derived miRNAs in pulmonary fibrosis","volume":"12","author":"Kishore","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2009.04.034","article-title":"Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation","volume":"138","author":"Kong","year":"2009","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0305","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.cca.2011.08.008","article-title":"Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)","volume":"412","author":"Kono","year":"2011","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdsr.2012.02.002","article-title":"CCN2 in orofacial tissue development and remodeling","volume":"48","author":"Kubota","year":"2012","journal-title":"Japanese Dental Science Review"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0315","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12079-011-0123-5","article-title":"The role of CCN2 in cartilage and bone development","volume":"5","author":"Kubota","year":"2011","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0320","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1515\/bmc-2013-0018","article-title":"The CCN family acting throughout the body: Recent research developments","volume":"4","author":"Kubota","year":"2013","journal-title":"Biomolecular Concepts"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0325","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nature Nanotechnology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2011.02.006","article-title":"Pulmonary delivery of therapeutic siRNA","volume":"64","author":"Lam","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0335","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2337\/diabetes.52.12.2975","article-title":"Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose","volume":"52","author":"Lam","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0340","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1513\/pats.200710-159DR","article-title":"Escape from the matrix: Multiple mechanisms for fibroblast activation in pulmonary fibrosis","volume":"5","author":"Laurent","year":"2008","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114882","article-title":"Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-\u03b2\/Smad signaling pathway","volume":"389","author":"Li","year":"2020","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0350","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtv.2009.11.004","article-title":"Fibroblasts and myofibroblasts in wound healing: Force generation and measurement","volume":"20","author":"Li","year":"2011","journal-title":"Journal of Tissue Viability"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0355","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3892\/ijmm.2015.2390","article-title":"Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (review)","volume":"36","author":"Li","year":"2015","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0360","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106057","article-title":"Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR\/Smad2\/3 signaling","volume":"176","author":"Liu","year":"2022","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0370","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1038\/s41598-017-11450-3","article-title":"Cholesterol-modified hydroxychloroquine-loaded nanocarriers in bleomycin-induced pulmonary fibrosis","volume":"7","author":"Liu","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0375","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12906-016-0991-6","article-title":"Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0380","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1139\/cjpp-2020-0662","article-title":"Alamandine via MrgD receptor attenuates pulmonary fibrosis via NOX4 and autophagy pathway","volume":"99","author":"Liu","year":"2021","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0385","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1091\/mbc.e13-08-0472","article-title":"CCN2 modulates hair follicle cycling in mice","volume":"24","author":"Liu","year":"2013","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0390","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10456-021-09795-5","article-title":"Characterization of the heterogeneity of endothelial cells in bleomycin-induced lung fibrosis using single-cell RNA sequencing","volume":"24","author":"Liu","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0395","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12931-016-0373-0","article-title":"Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung","volume":"17","author":"Lucattelli","year":"2016","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0400","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/09168451.2020.1721263","article-title":"The protective effect of Hederagenin on pulmonary fibrosis by regulating the Ras\/JNK\/NFAT4 axis in rats","volume":"84","author":"Ma","year":"2020","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0405","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0410","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125635","article-title":"Role of endothelial cells in pulmonary fibrosis via SREBP2 activation","volume":"6","author":"Martin","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0415","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Laboratory Investigation; A Journal of Technical Methods and Pathology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0420","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1242\/dev.01045","article-title":"Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex","volume":"131","author":"Mercurio","year":"2004","journal-title":"Development (Cambridge, England)"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0425","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbrc.2010.10.077","article-title":"Connective tissue growth factor is a substrate of ADAM28","volume":"402","author":"Mochizuki","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0430","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1164\/rccm.200810-1534OC","article-title":"Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis","volume":"179","author":"Moeller","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0435","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.matbio.2012.01.003","article-title":"Adhesion-modulating\/matricellular ECM protein families: A structural, functional and evolutionary appraisal. Matrix biol","volume":"31","author":"Mosher","year":"2012","journal-title":"Journal of the International Society for Matrix Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0440","series-title":"Simvastatin inhibits transforming growth factor-\u03b21-induced expression of type I collagen, CTGF, and \u03b1-SMA in keloid fibroblasts","first-page":"125","volume":"22","author":"Mun","year":"2014"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0445","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S2213-2600(21)00165-X","article-title":"Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: A post-hoc analysis of the INCREASE study","volume":"9","author":"Nathan","year":"2021","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0450","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.3390\/ijms21239084","article-title":"TGF-\u03b2 induced CTGF expression in human lung epithelial cells through ERK, ADAM17, RSK1, and C\/EBP\u03b2 pathways","volume":"21","author":"Ou","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0455","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.01.00074101","article-title":"Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF","volume":"17","author":"Pan","year":"2001","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0460","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hep.22079","article-title":"Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation","volume":"47","author":"Pi","year":"2008","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0470","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.24620","article-title":"Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen","volume":"60","author":"Ponticos","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0475","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0480","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/art.22559","article-title":"CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis","volume":"56","author":"Prasse","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0485","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0490","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1183\/13993003.01030-2015","article-title":"FG-3019 anti-connective tissue growth factor monoclonal antibody: Results of an open-label clinical trial in idiopathic pulmonary fibrosis","volume":"47","author":"Raghu","year":"2016","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0495","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","article-title":"Connective tissue growth factor (CTGF) from basics to clinics. Matrix biol","volume":"68\u201369","author":"Ramazani","year":"2018","journal-title":"Journal of the International Society for Matrix Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0500","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of Nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0505","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): A phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0510","first-page":"108","article-title":"Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition","author":"Rock","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0515","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1161\/HYPERTENSIONAHA.121.18201","article-title":"CCN2 (cellular communication network factor 2) deletion alters vascular integrity and function predisposing to aneurysm formation","volume":"79","author":"Rodrigues-D\u00edez","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0520","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.febslet.2011.01.004","article-title":"CTGF\/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy","volume":"585","author":"Rooney","year":"2011","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40259-018-0278-1","article-title":"Anticalin\u00ae proteins as therapeutic agents in human diseases","volume":"32","author":"Rothe","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0530","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II\u2013induced fibrosis","volume":"108","author":"Rup\u00e9rez","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0535","first-page":"55","article-title":"Epithelial mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis","author":"Salton","year":"2019","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0540","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.imlet.2015.04.003","article-title":"The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-\u03b21 pathway in human lung fibroblasts","volume":"165","author":"Schilter","year":"2015","journal-title":"Immunology Letters"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0545","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","article-title":"Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: A retrospective, multicentre cohort study","volume":"7","author":"Scott","year":"2019","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0550","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1513\/pats.200601-003TK","article-title":"Role of epithelial cells in idiopathic pulmonary fibrosis","volume":"3","author":"Selman","year":"2006","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109482","article-title":"The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis","volume":"66","author":"Selman","year":"2020","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0560","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/resp.12683","article-title":"Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history","volume":"21","author":"Sgalla","year":"2016","journal-title":"Respirology (Carlton, Vic.)"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0565","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1871530319666190823160230","article-title":"Curcumin suppresses epithelial growth factor receptor (EGFR) and proliferative protein (Ki 67) in acute lung injury and lung fibrosis in vitro and in vivo","volume":"20","author":"Shaikh","year":"2020","journal-title":"Endocrine, Metabolic & Immune Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0570","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0575","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/jcmm.12918","article-title":"Regulatory mechanisms of TGF-\u03b21-induced fibrogenesis of human alveolar epithelial cells","volume":"20","author":"Shi","year":"2016","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0580","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000055339","article-title":"Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis","volume":"61","author":"Shimo","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0585","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/jcmm.12667","article-title":"Complement inhibition decreases early fibrogenic events in the lung of septic baboons","volume":"19","author":"Silasi-Mansat","year":"2015","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0590","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1073\/pnas.0605652103","article-title":"Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins","volume":"103","author":"Sitar","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0595","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/art.27382","article-title":"Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis","volume":"62","author":"Sonnylal","year":"2010","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0600","article-title":"Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro","volume":"jcs.111302","author":"Sonnylal","year":"2013","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0605","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12931-018-0720-4","article-title":"Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab","volume":"19","author":"Sternlicht","year":"2018","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0610","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/stem.1648","article-title":"Tracking the elusive fibrocyte: Identification and characterization of collagen producing hematopoietic lineage cells during murine wound healing","volume":"32","author":"Suga","year":"2014","journal-title":"Stem Cells (Dayt. Ohio)"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0615","doi-asserted-by":"crossref","first-page":"8491487","DOI":"10.1155\/2018\/8491487","article-title":"A Chinese traditional therapy for bleomycin-induced pulmonary fibrosis in mice","volume":"2018","author":"Sun","year":"2018","journal-title":"Canadian Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0620","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.biomaterials.2012.09.061","article-title":"Noncovalenly PEGylated CTGF siRNA\/PDMAEMA complex for pulmonary treatment of bleomycin-induced lung fibrosis","volume":"34","author":"Sung","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0625","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12079-013-0204-8","article-title":"CCN2: A master regulator of the genesis of bone and cartilage","volume":"7","author":"Takigawa","year":"2013","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0630","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12079-017-0414-6","article-title":"An early history of CCN2\/CTGF research: The road to CCN2 via hcs24, ctgf, ecogenin, and regenerin","volume":"12","author":"Takigawa","year":"2018","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105961","article-title":"Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension","volume":"134","author":"Tam","year":"2021","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0640","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jcb.22132","article-title":"CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells","volume":"107","author":"Tan","year":"2009","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0645","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1465-9921-13-28","article-title":"Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts","volume":"13","author":"Tannheimer","year":"2012","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0650","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14656566.2020.1822326","article-title":"Pharmacological management of idiopathic pulmonary fibrosis: Current and emerging options","volume":"22","author":"Trachalaki","year":"2021","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0655","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12079-016-0347-5","article-title":"A potential role for CCN2\/CTGF in aggressive colorectal cancer","volume":"10","author":"Ubink","year":"2016","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0660","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/wrr.12946","article-title":"Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence","volume":"29","author":"Vierhout","year":"2021","journal-title":"Wound Repair and Regeneration"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0665","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0670","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar2973","article-title":"Attenuation of fibrosis in vitro and in vivo with SPARC siRNA","volume":"12","author":"Wang","year":"2010","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0675","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-4-4","article-title":"Cooperative interaction of CTGF and TGF-\u03b2 in animal models of fibrotic disease","volume":"4","author":"Wang","year":"2011","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0680","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1440-1843.2011.01938.x","article-title":"A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"16","author":"Wang","year":"2011","journal-title":"Respirology (Carlton, Vic.)"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0685","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2147\/TACG.S61999","article-title":"Candidate genes of idiopathic pulmonary fibrosis: Current evidence and research","volume":"9","author":"Wang","year":"2016","journal-title":"The Application of Clinical Genetics"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0690","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/01902148.2018.1543368","article-title":"CB2R agonist prevents nicotine induced lung fibrosis","volume":"44","author":"Wawryk-Gawda","year":"2018","journal-title":"Experimental Lung Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0695","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-019-1873-x","article-title":"Transforming growth factor (TGF)-\u03b21-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis","volume":"10","author":"Wei","year":"2019","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0700","first-page":"PA732","article-title":"Development of PRS-220, a potential best-in-class, inhaled CTGF\/CCN2 inhibitor for the treatment of IPF","volume":"58","author":"Welk","year":"2021","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0705","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tjog.2018.08.020","article-title":"EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2","volume":"57","author":"Wen","year":"2018","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0710","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BA20100031","article-title":"Bioscreening of phage display antibody library and expression of a humanized single-chain variable fragment antibody against human connective tissue growth factor (CTGF\/CCN2)","volume":"56","author":"Wu","year":"2010","journal-title":"Biotechnology and Applied Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0715","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ijbiomac.2019.11.192","article-title":"A novel peptide binding to the C-terminal domain of connective tissue growth factor for the treatment of bleomycin-induced pulmonary fibrosis","volume":"156","author":"Xiao","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0720","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/mt.2012.36","article-title":"miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice","volume":"20","author":"Xiao","year":"2012","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0725","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90558","article-title":"Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis","volume":"1","author":"Xu","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0730","first-page":"1","article-title":"Current models of pulmonary fibrosis for future drug discovery efforts","author":"Yanagihara","year":"2020","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0735","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1165\/rcmb.2020-0504OC","article-title":"Connective-tissue growth factor contributes to TGF-\u03b21\u2013induced lung fibrosis","volume":"66","author":"Yanagihara","year":"2022","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0740","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1755-3768.2009.01641.x","article-title":"The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-\u03b22, elucidated by treatment with CTGFsiRNA","volume":"88","author":"Yang","year":"2010","journal-title":"Acta Ophthalmologica"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0745","doi-asserted-by":"crossref","first-page":"L786","DOI":"10.1152\/ajplung.00243.2013","article-title":"Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor","volume":"306","author":"Yang","year":"2014","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"Biomarker Research"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0755","doi-asserted-by":"crossref","first-page":"566","DOI":"10.21037\/atm-22-1397","article-title":"Interference with connective tissue growth factor attenuated fibroblast-to-myofibroblast transition and pulmonary fibrosis","volume":"10","author":"Yang","year":"2022","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0760","article-title":"Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat","volume":"10","author":"Yao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.659627","article-title":"Effects of Nervilia fordii extract on pulmonary fibrosis through TGF-\u03b2\/Smad signaling pathway","volume":"12","author":"Yao","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0770","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12628","article-title":"17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice","volume":"3","author":"Yatomi","year":"2015","journal-title":"Physiological Reports"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0775","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3892\/ijmm.2021.4965","article-title":"TGF-\u03b21: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (review)","volume":"48","author":"Ye","year":"2021","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0780","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/01.ASN.0000130565.69170.85","article-title":"Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis","volume":"15","author":"Yokoi","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0785","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1074\/jbc.M115.693671","article-title":"Self-assembled micelle interfering RNA for effective and safe targeting of dysregulated genes in pulmonary fibrosis","volume":"291","author":"Yoon","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0790","doi-asserted-by":"crossref","first-page":"20002","DOI":"10.1074\/jbc.M700456200","article-title":"von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms","volume":"282","author":"Zhang","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0795","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1007\/s11033-021-06646-w","article-title":"M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1\/2, and STAT3 signaling pathways","volume":"48","author":"Zhang","year":"2021","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0800","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3389\/fimmu.2018.01216","article-title":"S100a4 is secreted by alternatively activated alveolar macrophages and promotes activation of lung fibroblasts in pulmonary fibrosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0805","doi-asserted-by":"crossref","first-page":"24476","DOI":"10.3390\/ijms141224476","article-title":"Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)\/ERK signaling pathway","volume":"14","author":"Zhu","year":"2013","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108578_bb0810","doi-asserted-by":"crossref","first-page":"25320","DOI":"10.18632\/oncotarget.4659","article-title":"Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition","volume":"6","author":"Zhu","year":"2015","journal-title":"Oncotarget"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823002425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823002425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:39:15Z","timestamp":1759012755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823002425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":161,"alternative-id":["S0163725823002425"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108578","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108578"}}